EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Treatment algorithm for pulmonary arterial hypertension

Kelly M Chin, Sean P Gaine, Christian Gerges iD, Zhi-Cheng Jing iD, Stephen C Mathai iD, Yuichi Tamura iD, Vallerie V McLaughlin, Olivier Sitbon iD

European Respiratory Journal · 2024-10 · 64 (4) · 2401325

DOI: 10.1183/13993003.01325-2024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Respiratory Journal, online erschienen am 29.08.2024. Verfasst von Kelly M Chin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, UT Southwestern, Dallas, TX, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Algorithms, Antihypertensive Agents, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 280-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension leads to significant impairment in haemodynamics, right heart function, exercise capacity, quality of life and survival. Current therapies have mechanisms of action involving signalling via one of four pathways: endothelin-1, nitric oxide, prostacyclin and bone morphogenetic protein/activin signalling. Efficacy has generally been greater with therapeutic combinations and with parenteral therapy compared with monotherapy or nonparenteral therapies, and maximal medical therapy is now four-drug therapy. Lung transplantation remains an option for selected patients with an inadequate response to therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationAlgorithmsAntihypertensive AgentsPulmonary Arterial HypertensionHumansHypertension, PulmonaryEpoprostenolNitric OxideEndothelin-1Quality of LifeDrug Therapy, CombinationHemodynamics

Substanzen

Antihypertensive AgentsEpoprostenolNitric OxideEndothelin-1

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, UT Southwestern, Dallas, TX, USA.
  • Department of Respiratory Medicine, National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Division of Cardiology, Department of Internal Medicine II, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan.

ORCID-Profile: Christian Gerges, Zhi-Cheng Jing, Stephen C Mathai, Yuichi Tamura, Olivier Sitbon

Zitieren

APA

Chin, K. M., Gaine, S. P., Gerges, C., Jing, Z. C., Mathai, S. C., Tamura, Y., McLaughlin, V. V., & Sitbon, O. (2024). Treatment algorithm for pulmonary arterial hypertension. European Respiratory Journal, 64(4), 2401325. https://doi.org/10.1183/13993003.01325-2024

Vancouver

Chin KM, Gaine SP, Gerges C, Jing ZC, Mathai SC, Tamura Y, et al. Treatment algorithm for pulmonary arterial hypertension. European Respiratory Journal. 2024;64(4):2401325. doi:10.1183/13993003.01325-2024

BibTeX
@article{Chin2024,
  author = {Chin, Kelly M and Gaine, Sean P and Gerges, Christian and Jing, Zhi-Cheng and Mathai, Stephen C and Tamura, Yuichi and McLaughlin, Vallerie V and Sitbon, Olivier},
  title = {Treatment algorithm for pulmonary arterial hypertension},
  journal = {European Respiratory Journal},
  year = {2024},
  volume = {64},
  number = {4},
  pages = {2401325},
  doi = {10.1183/13993003.01325-2024}
}
Kostenlos starten →